Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Finasteride may improve prostate cancer treatment outcomes.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Scalp cooling effectively reduces hair loss from chemotherapy.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Reporter characteristics affect detection of hair loss from cancer therapy.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Pancreatic cancer can alter gut and skin bacteria, possibly causing skin issues.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

A new method using gold nanoshells and infrared light effectively delivers siRNA to cancer and stem cells with precision and minimal damage.

Yoga helps manage PCOS symptoms and improves overall health.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Male pattern baldness does not cause an increased risk of prostate cancer.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Certain genetic variants increase the risk of aggressive prostate cancer.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Changes in SHBG levels don't predict diabetes risk reduction.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Reporter characteristics affect detection of hair loss from cancer therapy.